GILEAD SCIENCES, INC. is 93.2x more valuable than aTYR PHARMA INC by market capitalization ($150.83 B vs $1.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LIFE | GILD |
|---|---|---|
| Market cap | $1.62 B | $150.83 B |
| US-listed rank | #2252 | #99 |
| Revenue (latest FY) | $190.00K | $29.44B |
| Net income (latest FY) | -$74.12M | $8.51B |
| Net margin | -39009.5% | 28.9% |
| P/E (trailing FY) | - | 17.7 |
| SEC filings | 720 | 981 |
GILEAD SCIENCES, INC. is 93.2x more valuable than aTYR PHARMA INC by market capitalization ($150.83 B vs $1.62 B).
In their latest fiscal years, aTYR PHARMA INC reported $190.00K in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: aTYR PHARMA INC and GILEAD SCIENCES, INC., or browse the full rankings.